Novo Nordisk A/S Competitors
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
---|---|---|---|---|---|---|---|---|
JNJ | Johnson & Johnson | Outperform |
9
|
$146.14 | $174.55 | 16.33% | 3 | $356.43B |
MRK | Merck | Outperform |
2
|
$131.20 | $130.51 | 8.61% | 11 | $321.69B |
AZN | AstraZeneca PLC | Outperform |
17
|
£119.88 | £165.99 | 35.93% | 16 | £186.43B |
NOVN | Novartis | Hold |
10
|
CHF89.50 | CHF105.00 | 20.25% | 9 | CHF181.47B |
ROG | Roche Holding | Hold |
16
|
CHF221.00 | CHF307.83 | 23.30% | 9 | CHF178.76B |
ABT | Abbott Laboratories | Outperform |
9
|
$107.53 | $118.92 | 17.64% | 7 | $186.15B |
PFE | Pfizer | Outperform |
2
|
$25.40 | $32.87 | 20.08% | 6 | $147.23B |
AMGN | Amgen | Outperform |
4
|
$269.98 | $303.65 | 17.51% | 8 | $144.81B |
SAN | Sanofi | Outperform |
16
|
91.23€ | 102.80€ | 19.48% | 9 | 109.51€B |
BSX | Boston Scientific | Outperform |
11
|
$73.17 | $70.14 | 12.07% | 6 | $107.55B |
MDT | Medtronic | Outperform |
11
|
$79.74 | $92.47 | 19.76% | 21 | $105.54B |
BMY | Bristol-Myers Squibb | Hold |
2
|
$44.85 | $58.15 | 21.52% | 10 | $90.60B |
GSK | GSK | Outperform |
12
|
£16.53 | £17.30 | 17.97% | 12 | £67.54B |
CSL | CSL | Outperform |
12
|
$273.30 | $205.51 | -25.66% | 5 | $130.23B |
GILD | Gilead Sciences Inc | Outperform |
11
|
$65.42 | $87.82 | 22.29% | 14 | $81.58B |
SHW | Sherwin Williams | Outperform |
15
|
$306.45 | $317.38 | 10.78% | 9 | $77.87B |
4568 | Daiichi Sankyo Company | Buy |
4
|
¥5.01k | ¥5.24k | 15.77% | 0 | ¥9.61T |
4502 | Takeda Pharmaceutical Company | Outperform |
5
|
¥4.09k | ¥4.74k | 11.27% | 0 | ¥6.38T |
PPG | PPG Industries | Outperform |
13
|
$130.16 | $159.04 | 22.31% | 1 | $30.79B |
BIIB | Biogen | Outperform |
10
|
$208.90 | $299.62 | 38.10% | 13 | $29.36B |
BAYN | Bayer | Hold |
5
|
27.40€ | 45.15€ | 9.49% | 4 | 25.86€B |
HZNP | Horizon Therapeutics Public | - |
16
|
$115.69 | $116.50 | -100.00% | 0 | $23.58B |
ALNY | Alnylam Pharmaceuticals Inc | Outperform |
7
|
$143.31 | $245.24 | 50.02% | 7 | $18.26B |
500124 | Dr. Reddy's Laboratories | Hold |
18
|
Rp6.25k | Rp5.67k | -3.25% | 25 | Rp989.58B |
IPN | Ipsen | Outperform |
17
|
113.00€ | 127.95€ | 6.19% | 0 | 9.28€B |
SOBI | Swedish Orphan Biovitrum AB (p... | Outperform |
16
|
kr281.00 | kr293.00 | 15.66% | 6 | kr90.51B |
ARNA | Arena Pharmaceuticals | - |
6
|
$99.99 | $100.00 | -100.00% | 0 | $6.17B |
ZEAL | Zealand Pharma A/S | Outperform |
8
|
kr622.00 | kr357.00 | 31.03% | 2 | kr36.34B |
APN | Aspen Pharmacare Holdings | Outperform |
18
|
R220.71 | R202.49 | 5.18% | 1 | R96.56B |
GRF | Grifols | Outperform |
18
|
8.39€ | 18.48€ | 126.46% | 3 | 4.76€B |
CLN | Clariant | Outperform |
18
|
CHF13.26 | CHF16.11 | 13.12% | 6 | CHF4.33B |
PRGO | Perrigo Co PLC | Outperform |
16
|
$31.94 | $44.75 | 23.98% | 0 | $4.17B |
4403 | NOF | Buy |
18
|
¥2.09k | ¥7.63k | 35.60% | 0 | ¥495.24B |
PFIZER | Pfizer | Outperform |
18
|
Rp4.19k | Rp4.53k | 17.68% | 3 | Rp207.63B |
AMPH | Amphastar Pharmaceuticals | Outperform |
14
|
$41.11 | $69.00 | 50.81% | 0 | $1.96B |
AMRX | Amneal Pharmaceuticals | Outperform |
16
|
$5.87 | $6.13 | 27.77% | 1 | $1.78B |
XERS | Xeris Biopharma Holdings | Buy |
6
|
$1.75 | $4.60 | 171.43% | 1 | $244.39M |
ABEO | Abeona Therapeutics | Buy |
8
|
$3.26 | $21.25 | 421.47% | 2 | $207.08M |
NKTR | Nektar Therapeutics | Hold |
11
|
$1.32 | $2.75 | -24.24% | 2 | $171.69M |
BIOC | GlaxoSmithKline S.A.E | - |
14
|
£32.32 | £0.00 | -100.00% | 0 | £3.30B |
TXMD | TherapeuticsMD | - |
5
|
$2.26 | $5.00 | 3.10% | 0 | $27.14M |
ORGS | Orgenesis | - |
6
|
$0.28 | $9.00 | -46.43% | 0 | $16.26M |
ENZN | Enzon Pharmaceuticals | - |
0
|
$0.09 | $16.00 | -100.00% | 0 | $8.48M |
APVO | Aptevo Therapeutics | Buy |
-7
|
$0.71 | $7.38 | 94407.04% | 1 | $1.06M |
ACMELAB | The ACME Laboratories | - |
15
|
67.50 | 0.00 | -100.00% | 0 | 14.28B |
ACI | Advanced Chemical Industries | - |
12
|
138.20 | 0.00 | -100.00% | 0 | 10.53B |
SQURPHARMA | Square Pharmaceuticals PLC. | Buy |
0
|
207.70 | 318.00 | 53.59% | 0 | 195.02B |
SILCOPHL | Silco Pharmaceuticals | - |
0
|
16.60 | 0.00 | -100.00% | 0 | 1.79B |
RENATA | Renata | Hold |
0
|
977.10 | 0.00 | 15.96% | 0 | 146.00B |
BXPHARMA | Beximco Pharmaceuticals | Outperform |
0
|
116.10 | 153.50 | 32.21% | 0 | 62.05B |